Primary Record
Mevastatin
- In stock
- 5,984 g
- Purity
- 99.7 %
- CAS
- 73573-88-3
Compound Identifiers & Properties
- CAS
- 73573-88-3
- PubChem CID
- 64715
- SMILES
- CC[C@H](C)C(=O)O[C@H]1CCC=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O
- Canonical SMILES
- CC[C@H](C)C(=O)O[C@H]1CCC=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21
Names & Synonyms
- Mevastatin
- compactin
- Mevastatina
- Mevastatine
- 73573-88-3
- Mevastatinum
- Mevastatin [INN]
- kompaktin
- Antibiotic ML 236B
- ML-236B lactone
- ML236B lactone
- Mevastatin,
- Compactin;ML236B
- 6-demethylmevinolin
- Compactin lactone
- (+)-Compactin
- Statin I
- Mevastatinum [INN-Latin]
- ML-236B
- Mevastatin (Compactin)
- Compactin (penicillium)
- Mevastatin/Compactin
- Mevastatin, Compactin
- Mevastatine [INN-French]
- ML 236B lactone
- Mevastatina [INN-Spanish]
- Compactin[Penicillium]
- Mevastatin (Standard)
- Lovastatin EP Impurity A
- 1UQM1K0W9X
- Antibiotic ML-236B
- MEVASTATIN [MI]
- RefChem:53384
- UNII-1UQM1K0W9X
- AC1Q5WYM
- MEVASTATIN [JAN]
- ML 236 B
- CCRIS 4505
- CS 500
- CS-500
- DTXSID4040684
- CHEMBL54440
- D0J9GD
- C23H34O5
- AC1L21SK
- MEVASTATIN [MART.]
- SCHEMBL1116
- ML236B
- CS500
- MEVASTATIN [USP-RS]
- Lopac0_000754
- MFCD05662341
- DTXCID2020684
- CHEBI:34848
- MLS000721804
- MLS000759452
- MLS001424284
- MLS002207227
- AJLFOPYRIVGYMJ-INTXDZFKSA-N
- NSC281245
- GTPL3031
- Mevastatin - Bio-X trade mark
- orb1310389
- Mevastatin, >=96% (HPLC)
- NSC-281245
- NSC-759322
- CTK8B3049
- ERK5-4D09
- ML 236B
- HMS2052P07
- HMS2089D10
- HMS2232N09
- HMS3262G10
- HMS3268A19
- HMS3412H15
- HMS3676H15
- HMS3713B06
- CID64715
- KS-00000XT7
- MSK10322
- ZINC3833876
- Compactin, Mevastatinum, Mevastatina
- Tox21_111540
- Tox21_500754
- ANW-41687
- BBF-01732
- BDBM50011036
- HY-17408R
- NSC779705
- s4223
- AKOS015994712
- Mevastatin, >=95% (HPLC), powder
- C23-H34-O5
- CCG-101174
- CS-1234
- CS-O-30656
- DB06693
- EBC-615461
- FM25991
- KS-1085
- LP00754
- NC00424
- NSC 759322
- NSC-779705
- SDCCGSBI-0050732.P002
- L-637312
- SMP1_000077
- NCGC00025202-04
- NCGC00095942-01
- NCGC00261439-01
- BM164666
- CPD000336944
- HY-17408
- I518
- J12.081B
- L637312
- LS-46360
- Mevastatin 100 microg/mL in Acetonitrile
- SAM001246644
- SC-11548
- SMR000336944
- SY077144
- EC 700-442-0
- M02108
- AB0013739
- CAS-73573-88-3
- LOVASTATIN IMPURITY A [EP IMPURITY]
- TR-023864
- B1788
- EU-0100754
- M2275
- C13963
- H11997
- M 2537
- W-5323
- (1S,7S,8S,8aR)-8-(2-((2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl)-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (S)-2-methylbutanoate
- AB00588266-06
- AB00588266-08
- AB00588266_09
- Compactin, 6-Demethylvevinolin, CS-500, ML-236 B
- 573M883
- A837861
- Q414407
- SR-01000729493
- [(1S,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate
- A1204922
- Butanoic acid, 2-methyl-, (1S,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-7-methyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester, (2S)-
- SR-01000729493-4
- BRD-K94441233-001-03-1
- BRD-K94441233-001-12-2
- BRD-K94441233-001-13-0
- BRD-K94441233-001-17-1
- (1S,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate
- 7-(1,2,6,7,8,8a-Hexahydro-2-methyl-8-(2-methylbutyryloxy)naphthyl)-3-hydroxyheptan-5-olide
- (1S,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro-7-methyl-8-(2-((2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthyl (S)-2-methylbutyrate
- (1S,7S,8S,8aR)-8-(2-((2R,4R)-4-Hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl)-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl(2S)-2-methylbutanoate
- Mevastatin, 98%, a potent HMG-CoA reductase inhibitor - 1G 1g
- 58948-09-7
- Butanoic acid, 2-methyl-, (1S,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-7-methyl-8-(2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, (2S)-
- Butanoic acid, 2-methyl-, 1,2,3,7,8,8a-hexahydro-7-methyl-8-(2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, (1S-(1-alpha(R*),7-beta,8-beta(2S*,4S*),8a-beta))-
- 7-[1,2,6,7,8,8a-hexahydro-2-methyl-8-(methylbutyryloxy)naphthyl]-3-hydroxyheptan-5-olide
- ((1S,7S,8S,8aR)-8-(2-((2R,4R)-4-hydroxy-6-oxooxan-2-yl)ethyl)-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl) (2S)-2-methylbutanoate
- (1S,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate
- (1S,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl(2S)-2-methylbutanoate
- (2S)-2-Methyl-(1S,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-7-methyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl butanoate
- (2S)-2-Methylbutanoic acid (1S,7S,8S,8aR)-7-methyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1,2,3,7,8,8a-hexahydronaphthalene-1-yl ester
- (2S)-2-Methylbutanoic acid [(1S)-1,2,3,7,8,8aalpha-hexahydro-7alpha-methyl-8alpha-[2-[[(2R,4R)-tetrahydro-4beta-hydroxy-6-oxo-2H-pyran]-2alpha-yl]ethyl]naphthalene]-1beta-yl ester
- (2S)-2-Methylbutyric acid [(1S)-1,2,3,7,8,8aalpha-hexahydro-7alpha-methyl-8alpha-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]naphthalen-1beta-yl] ester
- (S)-((1S,7S,8S,8aR)-8-(2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-2H-pyran-2-yl)ethyl)-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl) 2-methylbutanoate
- (S)-((1S,7S,8S,8aR)-8-(2-((2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl)-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl) 2-methylbutanoate
- (S)-2-Methyl-butyric acid (1S,7S,8S,8aR)-8-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-7-methyl-1,2,3,7,8,8a-hexahydro-naphthalen-1-yl ester
- (S)-2-Methylbutyric acid [(1S,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-7-methyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]naphthalen-1-yl] ester
- [(1S,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxo-tetrahydropyran-2-yl]ethyl]-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate
- 2-Methyl-butyric acid 8-[2-(4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-7-methyl-1,2,3,7,8,8a-hexahydro-naphthalen-1-yl ester
- 2-Methyl-butyric acid 8-[2-(4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-7-methyl-1,2,3,7,8,8a-hexahydro-naphthalen-1-yl ester((+)-compactin)
- 2-Methyl-butyric acid 8-[2-(4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-7-methyl-1,2,3,7,8,8a-hexahydro-naphthalen-1-yl ester(compactin)
- 658-033-7
- 7-(1,2,6,7,8,8a-hexahydro-2-methyl-8- (2-methylbutyryloxy)naphthyl)-3-hydroxyheptan-5-olide
- 700-442-0
- Butanoic acid, 2-methyl-, 1,2,3,7,8,8a-hexahydro-7-methyl-8-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1-naphthalenyl ester, [1S-[1.alpha.(R*),7.beta.,8.beta.(2S*,4S*),8a.beta.]]-
- Lovastatin EP Impurity A; Pravastatin Deshydroxy Impurity; Mevastatin; Compactin (Penicillium)
- Mevastatin; (1S,7S,8S,8aR)-8-[2-[(2R,4R)-4-Hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl]-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-Methylbutanoate; Lovastatin Imp. A (EP); (2S)-2-Methylbutanoic acid (1S,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-7-methyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester; (+)-Compactin; Antibiotic ML 236B; CS 500; CS 500 (antibiotic); Compactin; Compactin (Penicillium); L 637312; ML 236B; ML 236B lactone; NSC 281245; Statin I; 2-Methylbutanoic acid [1S-[1alpha(R*),7beta,8beta(2S*,4S*),8abeta]]-1,2,3,7,8,8a-hexahydro-7-methyl-8-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1-naphthalenyl ester; Lovastatin Impurity A